But abstinence is often a superior bar similar to requiring that an antidepressant create full remission of depression or that an analgesic completely get rid of pain. Recognizing this limitation, the FDA encourages builders of opioid2 and stimulant3 use condition medicines to discuss with FDA alternative strategies to measure variations https://www.sgvascularctr.com/what-is-clacs/